A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin‐Chan(Hospital for Sick Children), Annie Huang(University of Toronto)Cancer CellJuly 1, 201910.1016/j.ccell.2019.06.002Cited by 85SaveCiteExport RISWatch citationsRelated PapersCNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity|Acta Neuropathologica|2014|159